Oct
2026
Fiera Milano, Italy
Visit us
stand 7B113, Integrated Pharma
KD Pharma
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:Switzerland
-
On CPHI since:2021
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 7B113, Integrated Pharma
Products Featured at CPHI Milan 2026
-
Product KD Pharma lipids APIs and Intermediates
Lipid Portfolio
Omega-3 APIs
· Largest producer of omega-3 APIs worldwide
· Ultra-high purity: EPA up to 99%, DHA up to 95%, tailored ratios
... -
Product Core Technologies and Services
• API / GMP Manufacturing • Rapid Process Development, Flawless Upscaling, and Economy of Scale-Production • Simulated-Moving Bed (SMB) Chromatography • Heterocyclic, Hazardous and Malodorous Chemistries • Organometallic and Cryogenic Chemistry • Transition-Metal Catalysis • High-Pressur... -
Product Fine Chemicals
SPECIAL TECHNOLOGIES AND REACTIONS
Special Technologies
• High-pressure reactions up to 64 bar: H2, CO, NH3, Amines, CO2 • Cryogenic: -80°C • Supercritical Fluid Chromatography (SFC), Simulated Moving Bed Chromatography (SMB) • Ultra low vacuum distillation • ... -
Product CONTRACT MANUFACTURING - SMALL MOLECULES
KD Pharma’s professional expertise, state-of-the-art assets and proven track record in regulatory compliance allow us to become your preferred CDMO solutions partner.
Your Agile Experts
• Responsive to our customers’ needs in a more dynamic customer-centric way • Adaptive to the most diverse re... -
Product ASYMMETRIC HYDROGENATION
We extensively address the specific needs of the pharmaceutical, food, cosmetics, agrochemicals and specialty chemicals industries with our capabilities in Transition Metal Catalysis (TMC) as applied to asymmetric hydrogenation. Complex active pharmaceutical ingredients (API’s) are often stereochemica...



